BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24556468)

  • 1. Hepatic necro-inflammation and elevated liver enzymes: evaluation with MRI perfusion imaging with gadoxetic acid in chronic hepatitis patients.
    Chen BB; Hsu CY; Yu CW; Kao JH; Lee HS; Liang PC; Wei SY; Hwang RM; Shih TT
    Clin Radiol; 2014 May; 69(5):473-80. PubMed ID: 24556468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients.
    Chen BB; Hsu CY; Yu CW; Wei SY; Kao JH; Lee HS; Shih TT
    Eur Radiol; 2012 Jan; 22(1):171-80. PubMed ID: 21879400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA.
    Ryeom HK; Kim SH; Kim JY; Kim HJ; Lee JM; Chang YM; Kim YS; Kang DS
    Korean J Radiol; 2004; 5(4):231-9. PubMed ID: 15637473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum markers for necroinflammatory activity in patients with chronic viral hepatitis and normal or mildly elevated aminotransferase levels.
    Cheong JY; Kim DJ; Hwang SG; Yang JM; Kim YB; Park YN; Cho SW
    Liver Int; 2011 Oct; 31(9):1352-8. PubMed ID: 21745311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined quantification of liver perfusion and function with dynamic gadoxetic acid-enhanced MR imaging.
    Sourbron S; Sommer WH; Reiser MF; Zech CJ
    Radiology; 2012 Jun; 263(3):874-83. PubMed ID: 22623698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
    Mendichovszky IA; Cutajar M; Gordon I
    Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of liver malignancy with gadoxetic acid-enhanced MRI: is addition of diffusion-weighted MRI beneficial?
    Kim YK; Kim CS; Han YM; Lee YH
    Clin Radiol; 2011 Jun; 66(6):489-96. PubMed ID: 21367403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing bolus dynamic contrast-enhanced (DCE) MRI assessment of hepatic perfusion: Initial experience.
    Baxter S; Wang ZJ; Joe BN; Qayyum A; Taouli B; Yeh BM
    J Magn Reson Imaging; 2009 Jun; 29(6):1317-22. PubMed ID: 19472388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
    Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
    Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and histologic implications of delayed hepatobiliary enhancement on magnetic resonance imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic Acid.
    Chen BB; Hsu CY; Yu CW; Wei SY; Kao JH; Lee HS; Shih TT
    Invest Radiol; 2012 Nov; 47(11):649-55. PubMed ID: 23011189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staging liver fibrosis by using liver-enhancement ratio of gadoxetic acid-enhanced MR imaging: comparison with aspartate aminotransferase-to-platelet ratio index.
    Motosugi U; Ichikawa T; Oguri M; Sano K; Sou H; Muhi A; Matsuda M; Fujii H; Enomoto N; Araki T
    Magn Reson Imaging; 2011 Oct; 29(8):1047-52. PubMed ID: 21775085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis.
    Kim AY; Kim YK; Lee MW; Park MJ; Hwang J; Lee MH; Lee JW
    Acta Radiol; 2012 Oct; 53(8):830-8. PubMed ID: 22847903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-Tesla magnetic resonance elastography for hepatic fibrosis: comparison with diffusion-weighted imaging and gadoxetic acid-enhanced magnetic resonance imaging.
    Park HS; Kim YJ; Yu MH; Choe WH; Jung SI; Jeon HJ
    World J Gastroenterol; 2014 Dec; 20(46):17558-67. PubMed ID: 25516671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.
    Kim HJ; Kim BS; Kim MJ; Kim SH; de Campos RO; Hernandes M; Semelka RC
    J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of liver function in thioacetamide-induced rat acute liver injury using an empirical mathematical model and dynamic contrast-enhanced MRI with Gd-EOB-DTPA.
    Saito S; Moriyama Y; Kobayashi S; Ogihara R; Koto D; Kitamura A; Matsushita T; Nishiura M; Murase K
    J Magn Reson Imaging; 2012 Dec; 36(6):1483-9. PubMed ID: 22711439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging--initial experience.
    Hagiwara M; Rusinek H; Lee VS; Losada M; Bannan MA; Krinsky GA; Taouli B
    Radiology; 2008 Mar; 246(3):926-34. PubMed ID: 18195377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of dynamic contrast-enhanced magnetic resonance imaging in evaluating liver fibrosis].
    Li XY; Xiong W; Han LJ; Zhang XL; Qiu SJ; Li SL
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(7):1259-63. PubMed ID: 21764710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma.
    Dutoit JC; Vanderkerken MA; Verstraete KL
    Eur J Radiol; 2013 Sep; 82(9):1444-52. PubMed ID: 23726124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypovascular hepatic nodule showing hypointensity in the hepatobiliary phase of gadoxetic acid-enhanced MRI in patients with chronic liver disease: prediction of malignant transformation.
    Takayama Y; Nishie A; Nakayama T; Asayama Y; Ishigami K; Kakihara D; Ushijima Y; Fujita N; Hirakawa M; Honda H
    Eur J Radiol; 2012 Nov; 81(11):3072-8. PubMed ID: 22673776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
    J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.